Literature DB >> 12605047

Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000.

Brigitte A Cowell1, Barry A Weissman, Karen K Yeung, Larisa Johnson, Sharon Ho, Rajana Van, David Bruckner, Bartly Mondino, Suzanne M J Fleiszig.   

Abstract

PURPOSE: To investigate the relationship between functional phenotype of and the associated human corneal infection.
METHODS: This was an experimental pilot study of patients presenting with corneal infections at the Jules Stein Eye Institute with presumed infection during the period from 12/30/97 to 9/1/00. Thirteen patients were admitted to the study based on positive identification of the causative pathogen as and patient consent. Data were collected (including bacterial cultures, lens wear schedule and care, gender and age, completed history questionnaire, clinical photographs). Statistical analysis of possible correlations was performed. Phenotypes of were determined, and clinical factors associated with infection were explored.
RESULTS: Both invasive and cytotoxic phenotypes of were isolated in equal proportion. Cytotoxic strains and invasive strains were found to be associated with patients younger than 50 years of age and older than 50 years of age, respectively.
CONCLUSIONS: remains a significant pathogen in corneal infection, especially during contact lens wear. The age of the patient may influence the phenotype of causing infection. Since invasive and cytotoxic strains have different effects on corneal cells, treatment of the infection might require different approaches depending on this phenotype of the causative bacteria.

Entities:  

Mesh:

Year:  2003        PMID: 12605047     DOI: 10.1097/00003226-200303000-00010

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

1.  Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis.

Authors:  Durga S Borkar; Suzanne M J Fleiszig; Chelsia Leong; Prajna Lalitha; Muthiah Srinivasan; Avanti A Ghanekar; Connie Tam; Wing Y Li; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  JAMA Ophthalmol       Date:  2013-02       Impact factor: 7.389

2.  P. aeruginosa infection increases morbidity in experimental cholesteatomas.

Authors:  Jae Y Jung; Dong H Lee; Eric W Wang; Robert Nason; Toni M Sinnwell; Joseph P Vogel; Richard A Chole
Journal:  Laryngoscope       Date:  2011-11       Impact factor: 3.325

3.  Histopathological Studies on Rabbits Infected by Bacteria Causing Infectious Keratitis in Human through Eye Inoculation.

Authors:  Yousef H Aldebasi; Hala A Mohamed; Salah M Aly
Journal:  Int J Health Sci (Qassim)       Date:  2014-07

4.  ExoS and ExoT ADP ribosyltransferase activities mediate Pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival.

Authors:  Yan Sun; Mausita Karmakar; Patricia R Taylor; Arne Rietsch; Eric Pearlman
Journal:  J Immunol       Date:  2012-01-16       Impact factor: 5.422

5.  Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections.

Authors:  Eric C Ledbetter; James J Mun; David Kowbel; Suzanne M J Fleiszig
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

6.  Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity.

Authors:  C Tam; S E Lewis; W Y Li; E Lee; D J Evans; S M J Fleiszig
Journal:  Exp Eye Res       Date:  2007-08-29       Impact factor: 3.467

Review 7.  Host defense at the ocular surface.

Authors:  Eric Pearlman; Yan Sun; Sanhita Roy; Mausita Karmakar; Amy G Hise; Loretta Szczotka-Flynn; Mahmoud Ghannoum; Holly R Chinnery; Paul G McMenamin; Arne Rietsch
Journal:  Int Rev Immunol       Date:  2013-02       Impact factor: 5.311

8.  Diversity of virulence phenotypes among type III secretion negative Pseudomonas aeruginosa clinical isolates.

Authors:  Jonida Toska; Yan Sun; Dalina Alvarez Carbonell; Altreisha N-S Foster; Michael R Jacobs; Eric Pearlman; Arne Rietsch
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.